The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Brace yourself for a bare-knuckled review of the health care outrages of 2012

Purchasing power

I learned a new texting acronym this year: SMH. It stands for “shaking my head.”

I did a lot of SMH in 2012.

This turned out to be a banner year for health care outrages. But there was one event that exceeded all expectations.

This past summer, GlaxoSmithKline executives weaseled out of a mountain of crushing legal woes. The Dept. of Justice let them write a check for $3 billion to avoid a variety of criminal and civil charges.

That’s what passes for justice — Big Pharma style.

DoJ officials tried to make it sound like real punishment. One official called the settlement “unprecedented in both size and scope.”

I guess that’s supposed to impress us. Here’s what it really is: A rigged system. Shameful to the core.

In the worst of their slime ball misdeeds, GSK executives hid risks of the type 2 diabetes drug Avandia. As a result, Avandia use may have played a role in thousands of deaths. GSK made billions. When the con was exposed, a fat check made all the problems go away.

Utterly despicable.

It doesn’t get any worse than that. But there were other shocking SMH moments we should note one more time before 2012 fades into the mist.

Worst of the worst

A whole lot of cornbread

Just as 2012 got underway, Paula Deen’s announcement that she had type 2 diabetes shocked almost nobody. After all, this was the celebrity cook who introduced the world to Krispy Kreme Bread Pudding. But one detail WAS shocking. She had been diabetic for three full years. During that whole time, of course, she promoted her rich, carb-laden recipes. And then the outrage… Paula’s type 2 “coming out” coincided with her new endorsement of type 2 diabetes drug Victoza. What a scam!

In the mouths of babes

This year, the FDA banned the use of BPA in baby bottles. As I’ve mentioned before, evidence shows that BPA may disrupt hormonal activity, while also promoting cancer, birth defects, heart disease, and type 2 diabetes. For years, scientists have known that BPA is potentially dangerous. And yet, someone developed a type of tooth filling for children that contains BPA. So they’ve banished BPA from baby bottles, but they’re embedding it in kids’ teeth!

Absolutely treacherous

A lawsuit exposed significant dangers in Aricept 23. This unnecessary Alzheimer’s drug was developed when lower doses of Aricept were about to lose patent. In a clinical trial, the much higher dose (23 mg) barely performed better than lower doses. But the dangers spiked off the charts. Patients who took the drug suffered far greater agitation, confusion, and fatigue. They were also more than three times more likely to experience vomiting. In Alzheimer’s patients, that can prompt a cascade of agonizing events. The FDA’s primary medical reviewer said Aricept 23 should not be on the market. So — of course — the agency approved it.

Off to a BadStart

This is one of the worst health care scams I’ve ever seen. And it’s a stunning violation of your trust. When you fill a prescription at Walgreens, you may get a phone call from a GoodStart agent. He’ll explain how important it is to take your meds. But the agent isn’t a Walgreens employee. He actually works for a company called Pleio. GoodStart is a Pleio program. Walgreens contracts Pleio to act as a Walgreens agent. So they don’t sell your prescription information to Pleio. They give it to Pleio. Technically, this isn’t a privacy violation. But they are using your personal information to generate revenue. Drug companies pay Walgreens to participate in the program. And drug companies benefit because patients are more likely to keep taking their drugs after talking to the GoodStart agent. Everyone wins! Except patients.

City-approved mother’s milk

Last spring, New York City Mayor Michael Bloomberg made headlines when he banned super-sized sodas. A couple of months later, another “health initiative” slid in under the radar. Bloomberg launched a campaign to pressure new moms to breastfeed. Now, I agree that breastfeeding is the best way. Also, nearly all formula products contain soy, which shouldn’t be given to infants. And finally, the flood of free formula samples in maternity wards and NICU departments needs to stop. But this is not the way to do it! Government officials should not attempt to force good health on citizens. It never works. And it never will.

Hide your daughters

Gardasil — the HPV vaccine — is the outrage that keeps on giving. In 2012, we saw two ridiculous Gardasil studies. One supposedly showed that the vaccine doesn’t prompt promiscuity in girls. But most of the girls in the study were very young. Many of them weren’t even teens when the study began. Equally frustrating was another study that linked Gardasil with two safety concerns… 1) Fainting on the day the shot is given. 2) Skin infections. So they want us to believe that THOUSANDS of serious Gardasil reactions reported to VAERS are just coincidences. This includes nearly 9,700 ER visits. More than 2,400 hospitalizations. More than 790 girls disabled. And well over 100 deaths. And as usual, media outlets dropped the ball. They parroted the “good news” without giving either study a critical eye.

No guiding light

In early 2010, I told you about the first studies confirming a link between statin drugs and increased type 2 diabetes risk. Almost two years later, in December 2011, Pfizer’s patent for Lipitor ended. Lipitor, of course, is the original statin and the best selling drug ever. Then, about two months later, in early 2012, the FDA finally issued a requirement for statin drugs to list diabetes risk. Hmmm. Did the FDA do Pfizer a huge favor by holding off on the diabetes warning for two years? I’ll answer that one with a question… If we found out the FDA did exactly that, would we be surprised? Meanwhile, not one major health organization has come forward with guidelines for the thousands (millions?) of type 2 patients who use statins.

SMH. Simply outrageous.

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.